- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced (Inoperable) Non Small Cell Lung Cancer in South Africa
Total 902 results
-
Mythic TherapeuticsRecruitingNon-Small Cell Lung Cancer | NSCLC | Advanced Non-Small Cell Lung Cancer | NSCLC Stage IV | NSCLC Stage IIIB | Advanced Non-Small Cell Squamous Lung Cancer | Advanced Non-Small Cell Non-Squamous Lung CancerUnited States, Australia, Korea, Republic of, United Kingdom
-
Bio-Thera SolutionsCompletedNon-squamous Non-small Cell Lung CancerChina, Mexico, South Africa, Turkey, Ukraine
-
Hummingbird BioscienceMerck KGaA, Darmstadt, GermanyRecruitingAdvanced or Metastatic Squamous Non-Small Cell Lung CancerAustralia, Singapore
-
Fox Chase Cancer CenterNational Comprehensive Cancer NetworkCompletedLocally Advanced Non-small Cell Lung CancerUnited States
-
Shanghai Henlius BiotechRecruitingNon-small Cell Lung Cancer | Locally Advanced or Metastatic Solid TumorsAustralia
-
University of SydneyAstraZeneca; Australasian Lung Cancer Trials GroupActive, not recruitingEGFR Mutant Advanced Non Small Cell Lung CancerTaiwan, Australia
-
NantCell, Inc.TerminatedAdvanced Squamous Non-Small Cell Lung CancerUnited States
-
Mirati Therapeutics Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung CancerUnited States, Korea, Republic of, Italy, Spain, Czechia, Hungary, Netherlands, Canada, Australia, Austria, Belgium, Germany, Ireland, Israel, Poland, United Kingdom, Taiwan, Portugal
-
European Organisation for Research and Treatment...CompletedLung CancerItaly, South Africa, United Kingdom, Netherlands, Poland
-
Merck Sharp & Dohme LLCActive, not recruitingAdvanced Non-Small Cell Lung CancerPoland, Russian Federation, United States, Australia, Canada, Hong Kong, Ireland, Italy, Japan, Korea, Republic of, Singapore, South Africa, Spain, Switzerland, Taiwan, United Kingdom
-
City of Hope Medical CenterOSI PharmaceuticalsCompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
R-PharmCompletedAdvanced/Metastatic Non-Small Cell Lung CancerGermany, Korea, Republic of, Russian Federation, Taiwan, Australia, Italy, France, United States, Argentina, Spain
-
ArriVent BioPharma, Inc.Allist Pharmaceuticals, Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung Cancer | EGFR Exon 20 MutationsUnited States, Australia, Spain, France, Italy, China, Japan, Korea, Republic of, Malaysia, Netherlands, Philippines, Singapore, Taiwan, Thailand, Brazil, Israel, United Kingdom
-
Checkpoint Therapeutics, Inc.TerminatedMetastatic Non-squamous Non Small Cell Lung CancerPeru, Russian Federation, South Africa, New Zealand, Georgia, Thailand, Brazil, Malaysia
-
Hellenic Oncology Research GroupUnknownNon Small Cell Lung CancerGreece
-
Regeneron PharmaceuticalsRecruitingAdvanced Non-Small Cell Lung CancerKorea, Republic of, United States, Malaysia, Australia, Georgia, Turkey
-
BayerRecruitingAdvanced Solid Tumors | Non-small Cell Lung CancerKorea, Republic of, Israel, United States, Japan, Australia
-
Eli Lilly and CompanyCompletedAdvanced Non-Small Cell Lung CancerUnited States
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedAdvanced or Metastatic Non-Small Cell Lung CancerUnited States, Australia, Brazil, Czech Republic, Russian Federation, Singapore
-
ArriVent BioPharma, Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung Cancer | Non-Small Cell Lung Cancer (NSCLC) | HER2 Exon 20 Mutations | EGFR Exon 20 Mutations | EGFR Uncommon Mutations, Including G719X and S768IUnited States, Australia, Spain, United Kingdom, France, Italy, China, Korea, Republic of, Canada, Japan, Netherlands
-
Bristol-Myers SquibbActive, not recruitingAdvanced Solid Tumors | Non-small Cell Lung CancerUnited States, Italy, Australia, Poland, Spain
-
PfizerRecruitingLocally Advanced or Metastatic ER+ HER2- Breast Cancer | Locally Advanced or Metastatic Castration-resistant Prostate Cancer | Locally Advanced or Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Korea, Republic of, Japan
-
Duke UniversityEli Lilly and CompanyTerminatedNon Small Cell Lung CancerUnited States
-
PfizerCompletedTrial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung CancerCarcinoma, Non-Small-Cell Lung (NSCLC)Ukraine, Poland, Romania, South Africa
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | Squamous Non Small Cell Lung Cancer | Nonsquamous Non Small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Singapore, Hong Kong, Canada
-
Worldwide Innovative Network AssociationPfizer; ARC Foundation for Cancer ResearchTerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIBIsrael, United States, Luxembourg, Spain
-
AbbVieActive, not recruitingAdvanced Solid Tumors Cancer | Non Small Cell Lung Cancer (NSCLC)United States, Australia, France, Israel, Japan, Korea, Republic of, Spain, Taiwan
-
Imugene LimitedActive, not recruitingNon Small Cell Lung Cancer | Non Small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IV | Squamous Non-small-cell Lung Cancer | Large Cell Carcinoma Lung | Adenocarcinoma LungUnited States, Australia
-
Daiichi Sankyo, Inc.CompletedNon-small Cell Lung CancerUnited States
-
International Atomic Energy AgencyCompletedNon Small Cell Lung CancerChile, China, Croatia, Egypt, India, Malaysia, Malta, Morocco, Pakistan, Panama, Peru, South Africa, Tunisia
-
TakedaActive, not recruitingAdvanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)United States, Spain, France, Korea, Republic of, Hong Kong, Australia, Taiwan, United Kingdom, Canada, Turkey, Italy, China, Germany, Japan, Austria, Belgium, Greece, Israel, Netherlands, Portugal, Russian Federation, Singapore, Sw... and more
-
Turning Point Therapeutics, Inc.TerminatedNon-Small Cell Lung Cancer | NSCLC | Non Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | ALK Gene MutationUnited States, Australia, Korea, Republic of
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Platinum-resistant Ovarian Cancer | Locally Advanced Solid Tumor | Post Anti-PD-1 Melanoma | 2L+ Cervical Cancer | Neoadjuvant Melanoma | Neoadjuvant Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Small Cell...United States, Australia, Korea, Republic of
-
University of NebraskaNational Cancer Institute (NCI)CompletedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
Western Sydney Local Health DistrictUniversity of Western SydneyRecruitingHepatitis | Lung Cancer, Non-small Cell | Lung Cancer Stage IVAustralia
-
Andrew SharabiPfizerTerminatedEarly Stage Non-Small Cell Lung CancerUnited States
-
Medical University of South CarolinaAltor BioScienceCompletedNon-small Cell Lung CancerUnited States
-
AbbottCompletedNon-small Cell Lung CancerUnited States
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | Squamous Non Small Cell Lung Cancer | Nonsquamous Non Small Cell Lung CancerPhilippines, Thailand, France, Korea, Republic of, Hong Kong, United States, Turkey, Malaysia, Taiwan, Brazil, Serbia, Greece, Slovakia, Peru, South Africa, Mexico, Vietnam, Bangladesh
-
Clovis Oncology, Inc.TerminatedLocally Advanced or Metastatic Non Small Cell Lung CancerUnited States, Australia, France, Poland
-
Novartis PharmaceuticalsCompletedNon Small Cell Lung CancerBelgium, Australia, Germany
-
AstraZenecaParexelRecruitingAdvanced or Metastatic Non-Small Cell Lung CancerChina, Netherlands, Korea, Republic of, Italy, Spain, Canada, Hungary, Japan, Argentina, France, United States, Taiwan, Poland, Serbia, United Kingdom, Hong Kong, Brazil, Germany, Belgium, Romania, India, Ireland, Australia
-
Mersana TherapeuticsCompletedSmall Cell Lung Cancer | Non-small Cell Lung CancerUnited States
-
Abion IncNovotech (Australia) Pty LimitedRecruitingAdvanced Solid TumorsAustralia, Korea, Republic of
-
National Cancer Institute (NCI)CompletedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer AJCC v7United States
-
Mayo ClinicMedical University of South CarolinaTerminatedNon Small Cell Lung CancerUnited States
-
AmgenTerminatedNSCLC | Non-small Cell Lung CancerUnited States, Austria, Australia
-
Julia K. Rotow, MDInivataActive, not recruitingMetastatic Non-Small Cell Lung Cancer | NSCLC Stage IVUnited States